Studies have also shown that E2 activates the ER through multiple genomic and nongenomic pathways in various tissues and organs.26 ERα/specificity protein-dependent activation of E2-responsive genes containing GC-rich promoters has been identified in breast and other cancer cell lines. This evidence concerns the gene ESR1 and cancer.